Veru Inc (VERU)

Sector:
CONSUMER STAPLES
Industry:
PERSONAL PRODUCTS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mitchell S. Steiner
Employees:
230
4400 BISCAYNE BOULEVARD, STE 888, MIAMI, FL 33137
3125959123

Veru Inc. focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company was formerly known as The Female Health Company.

Data derived from most recent annual or quarterly report
Market Cap 105.628 Million Shares Outstanding90.28 Million Avg 30-day Volume 744.9 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.08
Price to Revenue6.9943 Debt to Equity0.0 EBITDA-107.115 Million
Price to Book Value3.0557 Operating Margin-764.2661999999999 Enterprise Value88.866 Million
Current Ratio1.561 EPS Growth-1.262 Quick Ratio1.078
1 Yr BETA 1.4937 52-week High/Low 6.57 / 0.66 Profit Margin-734.4688
Operating Cash Flow Growth-262.3371 Free Cash Flow to Firm (FCFF) TTM -82.231 Million Free Cash Flow to Equity (FCFE) TTM-78.644 Million
Altman Z-Score-7.0929
View SEC Filings from VERU instead.

View recent insider trading info

Veru Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding VERU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VERU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-17 by RANKOWITZ MICHAEL L
  • 4: filed on 2023-11-17 by EISENBERGER MARIO
  • 4: filed on 2023-11-17 by LU LUCY
  • 4: filed on 2023-11-17 by HYUN GRACE
  • 4: filed on 2023-05-11 by GRECO MICHELE
  • 4: filed on 2023-05-11 by FISCH HARRY
  • 4: filed on 2023-05-11 by BARNETTE K GARY
  • 4: filed on 2023-05-11 by LU LUCY
  • 4: filed on 2023-05-11 by RANKOWITZ MICHAEL L
  • 4: filed on 2023-05-11 by STEINER MITCHELL SHUSTER

    • Events (8k)

  • 8-K: filed on 2023-11-15:
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
  • 8-K: filed on 2023-10-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-11:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-28:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RANKOWITZ MICHAEL L

    • Director
    		 0 2023-10-02 2

    LU LUCY

    • Director
    		 0 2023-10-02 2

    EISENBERGER MARIO

    • Director
    		 0 2023-10-02 2

    HYUN GRACE

    • Director
    		 0 2023-10-02 2

    STEINER MITCHELL SHUSTER PRESIDENT AND CEO

    • Officer
    • Director
    • 10% Owner
    		 0 2023-05-09 1

    BARNETTE K GARY CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-05-09 1

    GRECO MICHELE CHIEF ADMIN OFFICER AND CFO

    • Officer
    		 0 2023-05-09 1

    FISCH HARRY CHIEF CORPORATE OFFICER

    • Officer
    • Director
    		 0 2023-05-09 1

    SOCORRO JESUS

    • Director
    		 0 2020-11-13 0

    TODD CHARLES T JR CEO OF FHC DIVISION

    • Officer
    		 83,000 2019-01-02 0

    BETHUNE DAVID R

    • Director
    		 575,982 2018-10-31 0

    PARRISH O B

    • Director
    		 1,031,350 2018-06-28 0

    FRANK MARY MARGARET

    • Director
    		 0 2018-05-02 0

    GETZENBERG ROBERT CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2018-05-02 0

    HAINES DANIEL CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2017-12-14 0

    GROCH BRIAN J. CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2017-12-14 0

    PEERSCHKE ELGAR

    • Director
    		 0 2017-08-02 0

    MAKHOUL GEORGES

    • Director
    		 0 2017-08-02 0

    FELCH DONNA

    • Director
    		 No longer subject to file 2016-10-31 0

    TAYLER MARTIN CLIFFORD EXECUTIVE VP GLOBAL OPERATION

    • Officer
    		 No longer subject to file 2016-10-31 0

    FISCH HARRY

    K&H FISCH FAMILY PARTNERS, LLC

    • Director
    • 10% Owner
    		 648,907 2016-10-31 0

    LOVE ANDREW S JR

    • Director
    		 708,711 2016-08-16 0

    GARGIULO WILLIAM R JR

    • Director
    		 102,500 2016-05-23 0

    OSTROWSKI SUSAN EXEC VP OF SALES & MARKETING

    • Officer
    		 35,178 2015-09-30 0

    MECKES SHARON

    • Director
    		 0 2015-03-19 0

    KING KAREN LOUISE PRESIDENT AND CEO

    • Officer
    • Director
    		 69,500 2015-02-05 0

    DEARHOLT STEPHEN M

    • Director
    		 2,495,319 2015-01-16 0

    WENNINGER RICHARD E

    • Director
    		 1,986,565 2014-12-09 0

    POPE MICHAEL VP AND GENERAL MANAGER

    • Officer
    		 104,797 2011-12-09 0

    WALTON MICHAEL R

    • Director
    		 395,056 2011-06-27 0

    LEEPER MARY ANN

    • Director
    		 264,500 2010-12-16 0

    KERBER JAMES R

    • Director
    		 509,866 2008-03-17 0

    ZIC ROBERT VICE PRESIDENT-FINANCE

    • Officer
    		 28,750 2006-01-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VERU INC VERU 2023-12-08 22:15:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 21:45:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 21:15:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 20:45:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 20:15:07 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 19:45:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 19:15:03 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 18:45:03 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 18:15:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 17:45:03 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 17:15:03 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 16:45:05 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 16:15:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 15:45:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 15:15:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 14:45:04 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 14:15:03 UTC -7.2027 12.5227 800000
    VERU INC VERU 2023-12-08 13:45:03 UTC -7.0147 12.3347 800000
    VERU INC VERU 2023-12-08 13:15:04 UTC -7.0147 12.3347 800000
    VERU INC VERU 2023-12-08 12:45:05 UTC -7.0147 12.3347 800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments